Kwiterovich, P O <br/><br/>
Inhibition of protein tyrosine kinase alters the effect of serum basic protein I on triacylglycerols and cholesterol differently in normal and hyperapoB fibroblasts.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Aug 1995 
 - 1195-203 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.15.8.1195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apolipoproteins B--metabolism<br/>Benzoquinones<br/>Cholesterol--metabolism<br/>Cholesterol Esters--metabolism<br/>Fibroblasts--metabolism<br/>Genistein<br/>Humans<br/>Hyperlipoproteinemias--enzymology<br/>Isoflavones--pharmacology<br/>Lactams, Macrocyclic<br/>Mevalonic Acid--analogs & derivatives<br/>Nitriles--pharmacology<br/>Phenols--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proteins--pharmacology<br/>Quinones--pharmacology<br/>Rifabutin--analogs & derivatives<br/>Triglycerides--metabolism<br/>Tyrphostins